ALP-AMPPD POCT Platform Chemiluminescent Assay Test

CLIA-mate Features

• Stable ALP-AMPPD reaction system
• Innovative integrated design of magnetic separation and pipetting system
• Single test reagent cartridge without any reagent waste
• Disposable tip for each assay, reduce cross contamination
• Reagent information loading by external barcode scanner automatically
• Simplify mechanical movement design
• Understand how to use in 30min
• Totally free of maintenance
• 600 days MTBF

Clia-mate Chemiluminescence Immunoassay ALP-AMPPD platform

Product parameters:

Reagent advantages

• Excellent as CLIA
• Convenient as POCT
• Good test combination

Introduction

Clia-mate is a magnetic particle-based chemiluminescence immunoassay system with ALP-AMPPD principle. It combines the accuracy of CLIA technology with the flexibility and simplicity of POCT. All-in-one design of reagent cartridge and comprehensive test panels.The test menu concludes Cardiac markers, Inflammation markers, Fertility, Thyroid and so on, make CLIA-mate an ideal system for clinical departments, clinics, laboratories and even a supplement in central labs.

Easy operation

Installation→Power on and Log in→Reagent registration→Calibration→Quality control→Test

Company profile

Aikang Group is a national high-tech enterprise specialized in R&D, production, sales and service of medical devices. Founded in 2003, Aikang is headquartered in Shenzhen China and has established three R&D and production bases with a total area of 30,000 sqm and hundreds of employees.

Aikang has three Manufacture Bases:

Aikang MedTech Co., Ltd. for medical automation solutions, Aikang Diagnostic Co., Ltd. for in-vitro diagnostic solutions and Aisikang MedTech Co., Ltd. for medical consumables.